Meta Buys China's Manus to Boost AI Features
By Reuters | 29 Dec, 2025
The Singapore-based Chinese firm has shown AI agents capabilities it claims surpasses OpenAI's DeepResearch.
Meta said on Monday it would acquire Chinese artificial intelligence startup Manus, as the technology giant accelerates efforts to integrate advanced AI across its platforms.
Tech giants such as Meta have been ramping up AI investments through strategic acquisitions and talent hires as they navigate fierce industry competition. Earlier this year, the Facebook-owner invested in Scale AI in a deal valuing the data-labeling startup at $29 billion and bringing in its 28-year-old CEO, Alexandr Wang.
Financial terms of its deal with Manus were not released.
Singapore-based Manus makes general-purpose AI agent, which can operate as a digital employee, executing tasks such as research and automation independently and with minimal prompts.
Meta will operate and sell the Manus service, as well as integrate it into its consumer and business products, including in Meta AI, the company said.
Earlier this year, Manus launched its AI agent, claiming that its performance surpasses that of OpenAI's AI agent, DeepResearch.
The company, part of Beijing Butterfly Effect Technology Ltd Co, has marketed its product by completing dozens of tasks for users on X for free.
(Reporting by Harshita Mary Varghese in Bengaluru; Editing by Shilpi Majumdar)
Recent Articles
- Become an AI Bonus Baby—or Just Get Paid Like One
- Ferrari Denies Requiring Luce EV Purchase to Access to Limited Edition Models
- SpaceX Turns to Bond Sale to Fatten $100.8 Billion Cash Stash
- Google DeepMind Signs AI Research Deal with Film Studio A24
- China's 618 Shopping Festival Sees Flat E-Commerce Sales from Cautious Shoppers
- Amazon Prime Day to Gauge US Consumer Strain as Focus Shifts to Basics
- China Closing in but US Still Leads in Biotech Innovation
- EV Surge Likely to Cut Oil Demand by Late 2027
- Kunal Shah tapped to Lead Meta's WhatsApp
- AbbVie Bets $10.9 Billion on Apogee in Next-Generation Immunology Growth Push
